Form 4: Oracle CEO Safra Catz Exercises and Sells Over 3.7 Million Shares Under Pre-Planned Trading Program
Insider Transaction Report
Oracle Chief Executive Officer Safra Catz executed significant stock option exercises and subsequent sales of over 3.7 million shares of Oracle common stock in late June 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Oracle CEO Safra Catz exercised stock options for a total of 3,739,492 shares of Oracle common stock across two days: 1,873,791 shares on June 25, 2025, and 1,865,701 shares on June 26, 2025.
- The exercise price for these options was $51.13 per share.
- Concurrently with the exercises, Ms. Catz sold an equivalent number of shares, 3,739,492 shares in total, on the same dates.
- The sales on June 25, 2025, occurred at weighted average prices ranging from $210.6448 to $216.815 per share.
- The sales on June 26, 2025, occurred at weighted average prices ranging from $210.9257 to $213.6356 per share.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024, indicating pre-scheduled sales.
- Following these transactions, Safra Catz's direct beneficial ownership of Oracle common stock stands at 1,118,592 shares.
- The exercised options represented 2/7 of a performance-based option that vested upon certification of a performance goal by the Compensation Committee.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While large insider sales can sometimes be viewed negatively, these transactions were pre-planned under a Rule 10b5-1 plan, which is a common practice for executive compensation and liquidity management. The exercise of options also indicates the achievement of performance goals.
Positives
- The exercise of stock options at a strike price of $51.13, significantly below the market sale prices (ranging from $210.6448 to $216.815), indicates substantial unrealized gains for the executive.
- The vesting of performance-based options suggests the achievement of specific company performance goals, as certified by the Compensation Committee.
- The transactions were conducted under a pre-arranged Rule 10b5-1 plan, which helps mitigate concerns about insider trading based on non-public information.
Negatives
- The sale of a large volume of shares (over 3.7 million) by a key executive like the CEO could be perceived by some investors as a reduction in her direct stake, potentially signaling a lack of confidence, although this is often part of compensation and liquidity planning.
Risks
- No specific risks to the company's operations or financial health are disclosed in this Form 4 filing, as it primarily reports insider transactions. The inherent risks of stock ownership and market fluctuations apply.
Future Outlook
NA
Industry Context
This Form 4 filing is a standard disclosure of insider transactions and does not provide broader industry context or trends. It reflects an individual executive's compensation and liquidity management within the technology sector.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Safra Catz | NA | No change reported; Safra Catz is the current CEO. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Performance Goal Certification | The Compensation Committee certified a performance goal, leading to the vesting of performance-based options. | NA | Indicates the company's compensation structure is tied to performance metrics, aligning executive incentives with company goals. |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The sale of a significant number of shares by the CEO could lead to questions about management's long-term commitment, though the Rule 10b5-1 plan mitigates this concern. The exercise of options at a low price and sale at a high price demonstrates the executive's personal financial gain from the company's stock performance.
- Employees: No direct impact on employees is indicated by this filing.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2024-09-25 | Date Rule 10b5-1 Plan was adopted. |
| 2025-06-24 | Earliest transaction date; also the date 5,000,000 stock options became exercisable. |
| 2025-06-25 | Date of stock option exercise (1,873,791 shares) and subsequent sale of common stock. |
| 2025-06-26 | Date of stock option exercise (1,865,701 shares) and subsequent sale of common stock. |
| 2025-07-20 | Expiration date of the stock options. |
Keywords
Oracle, ORCL, Safra Catz, SEC Form 4, Insider Trading, Stock Options, Share Sale, Rule 10b5-1 Plan, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.